Found: 3183
Select item for more details and to access through your institution.
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).
- Published in:
- BioScience Trends, 2024, v. 18, n. 6, p. 505, doi. 10.5582/bst.2024.01394
- By:
- Publication type:
- Article
Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China.
- Published in:
- BioScience Trends, 2024, v. 18, n. 6, p. 495, doi. 10.5582/bst.2024.01423
- By:
- Publication type:
- Article
Angiogenesis inhibitors effects on overall survival and progression-free survival in newly diagnosed primary glioblastoma multiforme: a meta-analysis of twelve randomized clinical trials.
- Published in:
- Journal of Neuro-Oncology, 2025, v. 171, n. 2, p. 313, doi. 10.1007/s11060-024-04865-2
- By:
- Publication type:
- Article
Stem the blood flow: beneficial impact of bevacizumab on survival of subventricular zone glioblastoma patients.
- Published in:
- Journal of Neuro-Oncology, 2025, v. 171, n. 1, p. 201, doi. 10.1007/s11060-024-04828-7
- By:
- Publication type:
- Article
Identification of a Neutralizing scFv Binding to Human Vascular Endothelial Growth Factor 165 (VEGF165) Using a Phage Display Antibody Library.
- Published in:
- Applied Biochemistry & Biotechnology, 2008, v. 144, n. 1, p. 15, doi. 10.1007/s12010-007-8011-4
- By:
- Publication type:
- Article
Gold nanocrystals as potential inhibitors of tumor angiogenesis: implications in diagnosis and drug delivery.
- Published in:
- Journal of Nanoparticle Research, 2021, v. 23, n. 7, p. 1, doi. 10.1007/s11051-021-05276-4
- By:
- Publication type:
- Article
Anti-proliferative effects of gold nanoparticles functionalized with Semaphorin 3F.
- Published in:
- Journal of Nanoparticle Research, 2017, v. 19, n. 8, p. 1, doi. 10.1007/s11051-017-3967-7
- By:
- Publication type:
- Article
Anti-angiogenic activity and safety of intraocular application of triterpenes.
- Published in:
- Documenta Ophthalmologica, 2021, v. 143, n. 3, p. 259, doi. 10.1007/s10633-021-09841-z
- By:
- Publication type:
- Article
Psychological stress accelerates the onset of tumour formation and alters the type and location of tumours in a DMBA mouse carcinogenesis model.
- Published in:
- Stress & Health: Journal of the International Society for the Investigation of Stress, 2011, v. 27, n. 3, p. e129, doi. 10.1002/smi.1343
- By:
- Publication type:
- Article
Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case-based approach.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report.
- Published in:
- 2012
- By:
- Publication type:
- Report
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 4, p. 337, doi. 10.1007/s00280-023-04519-6
- By:
- Publication type:
- Article
Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 867, doi. 10.1007/s00280-021-04326-x
- By:
- Publication type:
- Article
Renin-angiotensin system inhibitors for countering proteinuria induced by angiogenesis inhibitors: a retrospective observational analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Advances in ovarian cancer therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Antiangiogenic tyrosine kinase inhibitors in colorectal cancer: is there a path to making them more effective?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
An apparent clinical pharmacokinetic drug-drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I study of pazopanib plus TH-302 in advanced solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population pharmacokinetics of lenalidomide in multiple myeloma patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sunitinib DDI with paracetamol, diclofenac, mefenamic acid and ibuprofen shows sex-divergent effects on the tissue uptake and distribution pattern of sunitinib in mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Population pharmacokinetics of bevacizumab in cancer patients with external validation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Changes in cross-sectional area of pulmonary vessels on chest computed tomography after chemotherapy in patients with advanced non-squamous non-small-cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The anti-angiogenic effect of dexamethasone in a murine hepatocellular carcinoma model by augmentation of gluconeogenesis pathway in malignant cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The novel EZH2 inhibitor, GSK126, suppresses cell migration and angiogenesis via down-regulating VEGF-A.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pharmacokinetic drug-drug interaction assessment of peptibody trebananib in combination with chemotherapies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 243, doi. 10.1007/s00280-015-2748-1
- By:
- Publication type:
- Article
Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 993, doi. 10.1007/s00280-015-2694-y
- By:
- Publication type:
- Article
Bevacizumab confers additional advantage to the combination of trastuzumab plus pertuzumab in trastuzumab‑refractory breast cancer model.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 3, p. 425, doi. 10.1007/s00280-012-1923-x
- By:
- Publication type:
- Article
Antiangiogenic therapy in the management of brain tumors: a clinical overview.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 3, p. 353, doi. 10.1007/s00280-012-1926-7
- By:
- Publication type:
- Article
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 333, doi. 10.1007/s00280-011-1685-x
- By:
- Publication type:
- Article
Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 173, doi. 10.1007/s00280-011-1681-1
- By:
- Publication type:
- Article
Different combination schedules of gemcitabine with endostar affect antitumor efficacy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 1, p. 239, doi. 10.1007/s00280-011-1695-8
- By:
- Publication type:
- Article
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 293, doi. 10.1007/s00280-010-1478-7
- By:
- Publication type:
- Article
Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 5, p. 1035, doi. 10.1007/s00280-010-1402-1
- By:
- Publication type:
- Article
Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 799, doi. 10.1007/s00280-010-1378-x
- By:
- Publication type:
- Article
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 315, doi. 10.1007/s00280-010-1320-2
- By:
- Publication type:
- Article
Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 935, doi. 10.1007/s00280-010-1243-y
- By:
- Publication type:
- Article
A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI<sup>™</sup>), in patients with advanced solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 425, doi. 10.1007/s00280-009-0968-y
- By:
- Publication type:
- Article
Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu<sup>+</sup> tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 2, p. 219, doi. 10.1007/s00280-008-0729-3
- By:
- Publication type:
- Article
A homodimeric IL-15 superagonist F4RLI with easy preparation, improved half-life, and potent antitumor activities.
- Published in:
- Applied Microbiology & Biotechnology, 2022, v. 106, n. 21, p. 7039, doi. 10.1007/s00253-022-12209-1
- By:
- Publication type:
- Article
Comprehensive optimization of precursor-directed production of BC194 by Streptomyces rochei MB037 derived from the marine sponge Dysidea arenaria.
- Published in:
- Applied Microbiology & Biotechnology, 2018, v. 102, n. 18, p. 7865, doi. 10.1007/s00253-018-9237-5
- By:
- Publication type:
- Article